Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 51655-256

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 51655-256). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 256 52 Rev A 03 23)

Label for Rosuvastatin Tablets, USP 10 mg, containing 30 film-coated tablets. The label includes storage instructions, manufacturer information (Northwind Pharmaceuticals), NDC 51655-256-52, and an emphasis on prescription use only. Additional product and packaging details appear on the label, including dosage form and lot information.*

FDA Label Image

Figure1 (Figure1)

A cumulative incidence line graph comparing Rosuvastatin calcium (Rosuvas) versus placebo over 5 years. The x-axis represents years, and the y-axis shows cumulative incidence percentage. Rosuvastatin shows a lower incidence curve compared to placebo, with hazard ratio (HR) 0.56, 95% confidence interval (0.46-0.69), and p-value <0.001. Below the graph, the number of subjects at risk for each group is presented at several time points.*

FDA Label Image

Figure2 (Figure2)

A data table displaying the number of events for various cardiovascular end points comparing Rosuvastatin calcium 20 mg and placebo 20 mg groups (each n=8901). Events listed include primary end point (MCE), cardiovascular death, nonfatal stroke, nonfatal myocardial infarction (MI), hospitalized unstable angina, and arterial revascularization, along with hazard ratios (HR), 95% confidence intervals (CI), and p-values. A hazard ratio plot accompanies the table, showing relative event risks visually.*

FDA Label Image

Figure3 (Figure3)

A boxplot chart comparing percent change from baseline in LDL-C levels across different doses of four statins: Rosuvastatin (10, 20, 40 mg), Atorvastatin (10, 20, 40, 80 mg), Simvastatin (10, 20, 40, 80 mg), and Pravastatin (10, 20, 40 mg). The vertical axis shows percent change, ranging from 0 to -75, illustrating LDL-C reduction at increasing dosages for each drug.*

FDA Label Image

Logo (Logo)

FDA Label Image

Logo1 (Logo1)

FDA Label Image

Structure (Structure)

Chemical structure of Rosuvastatin calcium showing the molecular arrangement of its atoms, including functional groups and calcium ion association.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.